Canada Life Assurance Co / REGN
Canada Life Assurance Co’s Regeneron Pharmaceuticals Position
Does Canada Life Assurance Co own Regeneron Pharmaceuticals (REGN)? Yes — 78.9K shares worth $61M (+0.11% of its 13F portfolio) as of Q1 2026, up from 75.2K shares the prior filed quarter.
Position Value
$61M
Q1 2026
Shares
78.9K
% of Portfolio
+0.11%
Quarters Held
29
currently held
Position History REGN
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 78.9K | $61M | +0.11% |
| Q4 2025 | 75.2K | $58M | +0.10% |
| Q3 2025 | 91.0K | $51M | +0.07% |
| Q2 2025 | 87.1K | $46M | +0.07% |
| Q1 2025 | 124.6K | $79M | +0.14% |
| Q4 2024 | 120.9K | $86M | +0.15% |
| Q3 2024 | 126.2K | $133M | +0.23% |
| Q2 2024 | 120.1K | $126M | +0.24% |
| Q1 2024 | 101.2K | $97M | +0.20% |
| Q4 2023 | 112.0K | $98M | +0.21% |
| Q3 2023 | 123.4K | $101M | +0.24% |
| Q2 2023 | 123.6K | $89M | +0.21% |
| Q1 2023 | 131.8K | $108M | +0.27% |
| Q4 2022 | 144.2K | $105M | +0.28% |
| Q3 2022 | 169.2K | $116M | +0.33% |
| Q2 2022 | 176.7K | $105M | +0.28% |
| Q1 2022 | 172.3K | $127M | +0.26% |
| Q4 2021 | 173.9K | $110M | +0.23% |
| Q3 2021 | 157.4K | $96M | +0.22% |
| Q2 2021 | 152.8K | $85M | +0.19% |
| Q1 2021 | 176.9K | $83M | +0.20% |
| Q4 2020 | 189.2K | $91M | +0.17% |
| Q3 2020 | 148.4K | $83M | +0.18% |
| Q2 2020 | 130.1K | $81M | +0.19% |
| Q1 2020 | 64.1K | $32M | +0.08% |
| Q4 2019 | 80.7K | $30M | +0.07% |
| Q3 2019 | 77.1K | $21M | +0.05% |
| Q2 2019 | 84.3K | $26M | +0.06% |
| Q1 2019 | 83.9K | $34M | +0.09% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Canada Life Assurance Co’s full portfolio or all institutional holders of REGN.